References
- Ehrenberger K, Brix R. Glutamic acid and glutamic acid diethyl ester in tinnitus treatment. Acta Otolaryngol (Stockh) 1983; 95: 599–605
- Eggermont J J. On the pathophysiology of tinnitus: A review and peripheral model. Hear Res 1990; 48: 111–24
- Eybalin M, Pujol R. Cochlear neuroactive substances. Arch Otorhinolaryngol 1989; 246: 228–34
- Felix D, Ehrenberger K. A microiontophoretic study of the role of excitatory amino acids at the afferent synapses of mammalian inner hair cells. Eur Arch Otorhinolaryngol 1990; 248: 1–3
- Ehrenberger K, Felix D. Glutamate receptors in afferent cochlear neurotransmission in guinea pigs. Hear Res 1991; 52: 73–80
- Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol Rev 1993; 73: 309–73
- Pujol R, Puel J L, Gervais d'Aldin C, Eybalin M. Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol (Stockh) 1993; 113: 330–4
- Ehrenberger K, Felix D. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptor: A survey. Acta Otolaryngol (Stockh) 1995; 115: 236–40
- Denk D-M, Brix R, Felix D, Ehrenberger K. Tinnitus therapy with transmitters. Tinnitus 91, JM Aran, R Dauman. Kugler, Amsterdam 1992; 119–21
- Tonndorf J. Stereociliary dysfunction, a cause of sensory hearing loss, recruitment, poor speech discrimination and tinnitus. Acta Otolaryngol 1991; 91: 469–71
- Denk D-M, Felix D, Ehrenberger K. Caroverine for therapy of cochlear-synaptic tinnitus. Proceedings of Inner Ear Neuropharmacology. Montpellier 1994
- Ehrenberger K, Denk D M, Felix D. Rezeptorphar-makologische Modelle fur eine kausale Tinnitustherapie (Receptor pharmacological models for a causal tinnitus therapy). Oto-Rhino-Laryngol Nova 1995; 5: 148–52
- Ehrenberger K, Felix D. Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: In vivo model for drug-induced neuroprotection. Neuropharmacology 1992; 31: 1259–63
- Cameron J R, Skafronick J G. Medical physics. Wiley & Sons, New York 1978
- StatXact-Turbo: Statistical software for exact nonpara-metric inference. Cytel Software Corporation, Cambridge, MA 1992
- Moller A R. Tinnitus. Neurootology, RK Jackler, D Brackmann. Mosby Year Book, St Louis 1994; 153–65
- Murai K, Tyler R S, Harker L A, Stouffer J L. Review of pharmacologic treatment of tinnitus. Am J Otol 1992; 13: 454–64
- Paaske P B, Pedersen C B, Kjems G, Sam I L. Zinc in the managemant of tinnitus. Placebo-controlled trial. Ann Otol Rhinol Laryngol 1991; 100: 647–9
- Lipton S A. Prospects for clinically tolerated NMDA antagonists: Open channel blockers and alternative redox states of nitric oxide. Trends Neurosci 1993; 16: 527–32
- Heiniger-Biirki C B, Ehrenberger K, Felix D. Is nitric oxide involved in inner ear neurotransmission. Prim Sensory Neuron 1995; 1: 41–6
- Franz P, Hauser Kronberger C, Bock P, Quint C, Baumgartner W. Localization of nitric oxide synthase I and III in the cochlea. Acta Otolaryngol (Stockh) 1996; 116: 726–31